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Implication for health policy/practice/research/medical education:
Idiopathic nodular glomerulosclerosis (ING) is a rare distinct clinicopathologic entity that has been linked to heavy tobacco 
smoking, chronic hypertension, obesity and insulin resistance. Its association with marijuana use is unknown. We report a case 
of  biopsy-proved ING in the absence of  pre-existing history of  diabetic nephropathy (DN) and heavy smoking. This report 
addresses the possible accentuation of  tobacco use risk by marijuana.
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Background: Nodular glomerulosclerosis is a characteristic histological finding of diabetic 
nephropathy (DN) with thickened glomerular basement membrane (GBM) and hyalinized 
arterioles. Idiopathic nodular glomerulosclerosis (ING), a rare distinct clinicopathologic 
entity, is the term used to denote classic DN confirmed by light microscopy, immuno-
fluorescence, and electron microscopy in the absence of diabetes mellitus (DM). ING 
has been linked to heavy tobacco smoking, chronic hypertension, obesity and insulin 
resistance. Its association with marijuana use is unknown. 
Case Presentation: We report a case of biopsy-proved ING in the absence of pre-existing 
history of DM and heavy smoking. This report addresses the possible accentuation of 
tobacco use risk by marijuana.
Conclusions: This report addresses the possible accentuation of tobacco use risk by marijuana.
ABSTRACT
1. Introduction
Nodular glomerulosclerosis, a histologic pattern of 
nodular mesangial sclerosis with glomerular lobulari-
ty, is the classic lesion of  diabetic nephropathy (DN) 
(1). The differential diagnosis for nodular glomerulo-
sclerosis is broad and includes membranoproliferative 
glomerulonephritis, amyloidosis, monoclonal immuno-
globulin deposition disease, fibrillary or immunotac-
toid glomerulonephropathy, glomerulopathy associat-
ed with a chronic hypoxic state (e.g., Takayasu’s arteri-
tis), and idiopathic nodular glomerulosclerosis (ING).
ING is rare and remains a diagnosis of  exclusion (2). 
The defining pathological features of  ING are dif-
fuse and nodular mesangial sclerosis accompanied by 
glomerular basement membrane (GBM) thickening, 
glomerulomegaly, and arteriolosclerosis. It is strongly 
associated with hypertension and heavy smoking. We 
report a case of  ING in a chronic marijuana user with 
insignificant history of  tobacco use and no history of 
DM.
2. Case Report 
A 36-year-old African-American female with insignifi-
cant medical history presented to the emergency room 
with chief  complaint of  daily vomiting for one week, 
poor appetite, and unintentional weight loss of  35 kg 
over one year. She also had been experiencing migraine 
headaches and was taking ibuprofen chronically. Nine 
years earlier, she had taken antihypertensive medication 
for six months after her last pregnancy with no his-
tory of  preeclampsia or chronic hypertension (HTN) 
known prior to the pregnancy. Despite systolic blood 
pressure (BP) readings of  150-170 mm Hg recorded 
5 months prior to this admission; she was on no anti-
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hypertensive medication. She had no diabetes mellitus 
(DM). Her family history was negative for autoimmune 
diseases, but her mother and sister both had HTN and 
DM. She had no allergies and denied the use of  any 
herbal remedies. She had started smoking tobacco ciga-
rettes socially at age 25 and smoked up to five cigarettes 
per day before quitting a year ago. She had significant 
history of  using marijuana starting 10 years ago and 
had been smoking twice a day for the last five years 
prior to admission. She denied use of  other illicit drugs 
or heavy drinking. 
On examination, she was afebrile and her BP measured 
195/103 mm Hg with a regular pulse of  103 beats/
minute. Oxygen saturation was 100% on room air. Her 
body mass index was 29 kg/m2. Physical examination 
was otherwise unremarkable except for pale conjuncti-
va. Laboratory parameters showed microcytic anemia 
with hemoglobin of  4.9 g/dL and iron saturation of 
4% with a ferritin level of  13 ng/mL. Stool was neg-
ative for occult blood. Erythrocyte sedimentation rate 
was 66 mm/h. Her urine and blood culture were both 
negative. Her renal function was as follows: blood urea 
nitrogen 87 mg/dL; creatinine 10.9 mg/dL (1.0 mg/
dL 5 years earlier); bicarbonate 12 mEq/L; potassium 
5.1 mEq/L. Phosphorus was 8.3 mg/dL with elevat-
ed parathyroid hormone of  1,729 pg/mL. Urinalysis 
showed 3+ protein at specific gravity of  1.008 with-
out any red blood cells. Spot random urine revealed 
a protein to creatinine ratio of  384/77 mg/dL with 
a serum albumin of  3.6 g/dL. Total cholesterol was 
151 mg/dL with low-density lipoprotein being 82 mg/
dL. Anti-neutrophil antibody, serum complement lev-
els, hepatitis and HIV screening were all negative or 
normal. Fasting blood glucose was normal, and HgbA1c 
was 5.3%. Urine drug screen was positive for canna-
binoid (delta-9-tetrahydrocannabinol [TCH], and oth-
er derivatives). Renal ultrasound demonstrated a right 
kidney size of  10.4 cm and left kidney of  10.8 cm in 
length with increased cortical echogenicity without hy-
dronephrosis. Her echocardiography showed moderate 
concentric left ventricular hypertrophy, normal ejection 
fraction, and moderate pulmonary hypertension. Renal 
biopsy was done for unchanged renal function despite 
volume resuscitation with packet red blood cell trans-
fusions and blood pressure control. 
2.1. Renal biopsy 
On light microscopy, the glomeruli showed extensive 
diffuse and nodular glomerulosclerosis (Figure 1). 
Several of  the GBM appeared thickened with a few 
glomeruli contained intra-capillary hyaline. There was 
no mesangial/endocapillary cell proliferation or dou-
ble contouring, and no immune complex deposits were 
identified. One glomerulus showed wrinkling of  the 
GBM consistent with ischemic change. There was dif-
fuse interstitial fibrosis and tubular atrophy extending 
throughout the cortex. Several arterioles showed hya-
line arteriolosclerosis. Immunofluorescence was only 
positive for segmental IgM in 2/8 glomeruli, but other-
wise negative for human IgG (heavy and light chains), 
IgG (gamma chain), IgA, kappa light chain, lambda 
light chain, C1q, C3, C4, albumin, and fibrinogen. Elec-
tron microscopy of  two of  glomeruli showed widening 
of  the mesangial areas by mesangial matrix (diffuse glo-
merulosclerosis) and areas of  nodular glomeruloscle-
rosis. The GBM was thickened with a mean thickness 
of  616 ±- 50 nm. The visceral epithelial cells showed 
large areas of  foot processes effacement (Figure 2). 
There was no immune complex deposition or deposits 
compatible with light chain seen. There was no fibril-
lary material compatible with amyloid or fibrillary glo-
merulonephritis.
3. Discussion
Once considered a diagnosis of  exclusion, ING is a 
rare distinct clinicopathologic entity (2). It is predom-
inantly described in elderly Caucasian individuals and 
Figure 1. Light microscopy of  idiopathic nodular glomerulosclerosis 
(H&E original magnification × 200): The glomerulus shows 
extensive diffuse nodular glomerulosclerosis.
Figure 2. Electron microscopy of  idiopathic nodular 
glomerulosclerosis (original magnification × 14300): There is 
widening of  the mesangial areas by increased mesangial matrix and 
thickened glomerular capillary basement membrane. There is diffuse 
foot process effacement.
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is linked to heavy smoking, hypertension, and obesity 
(3,4). Patients usually present with renal insufficiency 
and proteinuria of  variable degrees. The pathogenesis 
involves the interplay of  hypertension, heavy smoking, 
increased glomerular extracellular matrix (ECM) and 
angiogenesis (5). 
Tobacco smoking has a negative impact on renal func-
tion, particularly in a patient with hypertension, DM, 
and primary renal disease (6). It increases the risk of  al-
buminuria, progression to proteinuria, and renal func-
tional impairment, particularly in men and the elderly. 
The pathophysiologic mechanisms include the forma-
tion of  advanced glycation end-products (AGEs) by 
glycotoxins, induction of  oxidative stress, angiogenesis, 
and altered intrarenal hemodynamics (7,8). Induction 
of  oxidative stress by free radicals contained in ciga-
rette smoke and directly by AGE increases ECM. AGE 
alters ECM by promoting mesangial cell synthesis of 
fibrogenic cytokines, platelet-derived growth factor, 
insulin growth factor (IGF) and transforming growth 
factor-beta (TGF-β) (9). Furthermore, smoking di-
rectly and indirectly, through chronic hypoxia, leads to 
sympathetic activation and stimulation of  the renin-an-
giotensin aldosterone system; it promotes increased 
renal vascular resistance, decreased renal plasma flow, 
hypertension, and ECM production. In addition, AGE 
interacts with its receptor RAGE, which is predomi-
nantly expressed in podocytes. Podocytes play a crucial 
role in the pathogenesis of  glomerulosclerosis and pre-
vent proteinuria through a complex regulation of  actin 
cytoskeleton in their foot processes. They are insulin 
responsive cells and their function, structure, and sur-
vival are under the control of  insulin stimulation (10). 
Respectively, podocyte-specific insulin resistance is 
considered a potential mechanism of  glomerular kid-
ney damage (11). 
Our patient presented with advanced renal insuffi-
ciency, nephrotic range proteinuria, and untreated hy-
pertension of  unknown duration. Her renal function 
remained impaired despite volume resuscitation with 
packed red blood cells and blood pressure control. 
Kidney biopsy findings of  diffuse and nodular glomer-
ulosclerosis, GBM thickening, and arteriolar hyalinosis 
favored a diagnosis of  diabetic glomerulosclerosis, but 
there was no evidence of  diabetes or impaired glucose 
tolerance on biochemical testing and available records 
from the past. There were no immune deposits on 
immunofluorescence and no fibrillar or microtubular 
structures on electron microscopy. The patient’s nega-
tive serology tests led us to diagnose ING with features 
of  hypertensive vascular changes. Interestingly, though 
she was not a heavy tobacco smoker, she used marijua-
na daily.
Cannabis is the most widely used illicit drug after to-
bacco and alcohol. There is a rising interest in its ther-
apeutic use for chemotherapy-induced nausea and 
vomiting, HIV-associated anorexia, neuropathic pain 
in multiple sclerosis, pain associated with rheumatoid 
arthritis, fibromyalgia, and cancer (12). Respectively, 
its safety is an emerging source of  concern. Marijuana 
is an ill-defined conglomerate of  chemicals. Its short- 
and long-term adverse effects are difficult to evaluate 
because often there is a concurrent consumption of  to-
bacco and alcohol. Delta-9-tetrahydrocannbinol (TCH) 
is mainly metabolized in the liver by cytochrome P-450 
and appears to be responsible for the principle toxi-
cological effect. Its effects are dose dependent and 
range from serious psychological to somatic disorders, 
including tachycardia and dyspnea progressing to ap-
nea and death. Excessive use of  marijuana, as expe-
rienced by our patient, could result in a cyclic vomit-
ing, a condition called ‘cannabinoid hyperemesis syn-
drome’ (13). The long-term cardiovascular effects and 
associated health risks with chronic use of  marijuana 
remain unknown. Acutely, there is a dose-dependent 
tachycardia and modest increase in blood pressure via 
centrally mediated beta-sympathetic stimulation and 
reduced parasympathetic activity (14). Decreased vas-
cular resistance associated with increased blood flow 
to the extremities may cause postural hypotension and 
even syncope (15). Although it is difficult to determine 
the effect of  marijuana in our patient’s renal pathology 
and the diagnosis of  ING, her insignificant smoking 
history strongly suggests that chronic use of  marijuana 
has played a significant role or may have accentuated 
the risk of  development of  ING associated with to-
bacco use. Smoking causes carbon monoxide-induced 
hypoxia and, compared to one tobacco cigarette, a mar-
ijuana cigarette increases the carboxyhemoglobin levels 
by fivefold resulting in tissue hypoxia (16). Moreover, 
cases of  arteritis associated with marijuana use leading 
to ischemia have been described (17). Finally, marijuana 
produces oxidative stress increasing ECM via TGF-be-
ta and IGF as outlined above (18).
Our case is unique in that the patient was a young Afri-
can American female with relatively insignificant tobac-
co smoking history but chronic daily marijuana use for 
over 10 years. This contrasts with the two biggest case 
series reported by Columbia University (1996-2001) 
(4), where most patients were old, white, heavy-smok-
ing males and the University of  Texas/Houston (1998-
2007) (3) where most patients were females. This gen-
der distribution in the two biggest case series could be 
due to the sampling period with smoking becoming 
more prevalent among females over the last decades. 
4. Conclusions
The pathogenesis of  ING remains unclear and the 
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prognosis is poor. It involves the interplay of  hyper-
tension, obesity, insulin resistance and heavy smoking. 
Chronic use of  marijuana may accentuate the tobacco 
risk. Although illegal in many countries, marijuana use 
is widespread, especially among the adolescents and 
young adults, for its euphoric effects. With the rising 
therapeutic use of  cannabis-based medicine, it is im-
portant that physicians be equally vigilant about the 
possible long-term renal toxicity effects of  marijuana 
beyond the acute kidney injury seen with cannabinoid 
hyperemesis syndrome.
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